Mark Efird
Physician Assistant · Gastonia, NCNPI 1609832591
Payments from drug & device makers
Across 744 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$1K
- Lilly USA, LLC$1K
- Bayer$688
- Novo Nordisk$638
- AstraZeneca$604
- plus $7K from 41 others
What the payments were for
- Food & beverage$11,903100%
- Education$420%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,944 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $52,571 |
| FarxigaDapagliflozin Propanediol | 28 | $36,980 |
| TrulicityDulaglutide | 38 | $35,953 |
| OzempicSemaglutide | 22 | $24,653 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 34 | $18,685 |
| XareltoRivaroxaban | 24 | $15,343 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $13,433 |
| OxycontinOxycodone Hcl | 14 | $11,976 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $9,743 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,031 |
| InvokametCanagliflozin/Metformin Hcl | 12 | $6,917 |
| Novolog FlexpenInsulin Aspart | 31 | $5,211 |
| SynthroidLevothyroxine Sodium | 48 | $4,406 |
| Mesalamine ErMesalamine | 11 | $2,481 |
| Wixela InhubFluticasone Propion/Salmeterol | 18 | $2,365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,164 | $52,57161 claims |
| AstraZenecaFarxiga | $604 | $36,98028 claims |
| Lilly USA, LLCTrulicity | $1,056 | $35,95338 claims |
| Novo NordiskOzempic | $638 | $24,65322 claims |
| Johnson & JohnsonXarelto, Invokamet | $522 | $22,26036 claims |
| Boehringer IngelheimSynjardy Xr | $556 | $18,68534 claims |
| GSKTrelegy Ellipta | $280 | $9,03114 claims |
| AbbVieSynthroid | $1,125 | $4,40648 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Gastonia
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.